Skip to content
DraconiticResearch
Search Sources API
201,683 studies31 sourcesUpdated 47 min ago
PreprintCC BYbioRxiv

Differential LncRNA expression profile in the plasma of preeclampsia and normal pregnancies

  1. 1The Second Xiangya Hospital of Central South University

Abstract

Background: Early detection of preeclampsia with noninvasive and reliable biomarkers is the foremost step for minimizing adverse effects during pregnancy. However, none maternal serum analyte evaluated so far is sufficiently accurate to allow recommending their routine use. Methods: Microarray was used to first identify differentially expressed LncRNA and mRNA. Gene ontology (GO) and the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses were performed to determine bio-functions and signaling pathways. Quantitative real-time polymerase chain reaction was used to validate the results of microarray. Finally, the lncRNA-mRNA co-expression network was constructed to find the interaction of genes. Result: A total of 1476 differentially expressed lncRNAs and 594 mRNAs were identified. Both RNA-seq and RT-qPCR showed the expression of T241171,T338586, uc002ywy.3 was up-regulated, and the expression of ENST00000524858, T131416, T357032, uc.335+ was down regulated in the plasma of patients with preeclampsia. Pathway analysis showed the targeted mRNAs were enriched in apoptosis, sulfur metabolism, starch and sucrose metabolism. ceRNA network found that LncRNA-uc002ywy.3 might be the upstream regulator of miRNA-4498. LncRNA-uc002ywy.3/miRNA-4498 was predicted to interplay with genes involved in programmed cell death-1and its ligand (PD-1/PD-L1) pathway by KEGG analysis. Conclusion s PD-1/PD-L1 signaling pathway may be involved in the development of preeclampsia. The dysregulated LncRNA-uc002ywy.3/miRNA-4498 shed light on a new layer involved in the regulatory network of preeclampsia.

Related

  1. Comparative analysis of maternal diet and its individual compounds in pregnancies with and without preeclampsia
    Marta Larroya, Irene Casas, Mariona Genero +20
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textObstetrics, gynaecology & paediatricsCrossref
  2. The severity of preeclampsia in naturally conceived versus IVF-conceived pregnancies: a retrospective study
    Yu Chen, Pin Jiang, Xiaoshuang Li +4
    Hypertension in PregnancyPeer-reviewedCC BYFull textObstetrics, gynaecology & paediatricsDOAJ
  3. Early maternal plasma protein signatures identify preeclampsia risk in twin pregnancies
    J. Li, Z. Fang, W. Tian +10
    medRxivPreprintPublic domainFull textObstetrics, gynaecology & paediatricsmedRxiv
  4. LncRNA A1BGAS1 Serves as a Tumor Suppressor in Non-Small Cell Lung Cancer by Modulating the Expression of miR-3942-5P.
    Jiahui Du, Zhenhua Li, Chunqiang Wang +1
    Journal of biochemical and molecular toxicologyPeer-reviewedCC BY-NCFull textOncologyEurope PMCPMC
  5. Investigating long non-coding RNA (lncRNA) HOTAIR expression changes in ischemic stroke patients.
    Alia Saberi, Niloufar Nabavi, Amirreza Ghayeghran +6
    BMC research notesPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCDOAJ
BibTeX
@misc{peng2026differential,
  title = {{Differential LncRNA expression profile in the plasma of preeclampsia and normal pregnancies}},
  author = {L. Peng and W. Lai and J. Huang and Y. Zhong},
  howpublished = {bioRxiv},
  year = {2026},
  month = sep,
  doi = {10.64898/2026.09.01.748658},
  url = {https://www.biorxiv.org/content/10.64898/2026.09.01.748658v1},
  note = {CC BY},
}
RIS
TY  - UNPB
TI  - Differential LncRNA expression profile in the plasma of preeclampsia and normal pregnancies
AU  - L. Peng
AU  - W. Lai
AU  - J. Huang
AU  - Y. Zhong
PY  - 2026
DA  - 2026/09/01
PB  - bioRxiv
DO  - 10.64898/2026.09.01.748658
UR  - https://www.biorxiv.org/content/10.64898/2026.09.01.748658v1
AB  - Background: Early detection of preeclampsia with noninvasive and reliable biomarkers is the foremost step for minimizing adverse effects during pregnancy. However, none maternal serum analyte evaluated so far is sufficiently accurate to allow recommending their routine use. Methods: Microarray was used to first identify differentially expressed LncRNA and mRNA. Gene ontology (GO) and the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses were performed to determine bio-functions and signaling pathways. Quantitative real-time polymerase chain reaction was used to validate the results of microarray. Finally, the lncRNA-mRNA co-expression network was constructed to find the interaction of genes. Result: A total of 1476 differentially expressed lncRNAs and 594 mRNAs were identified. Both RNA-seq and RT-qPCR showed the expression of T241171,T338586, uc002ywy.3 was up-regulated, and the expression of ENST00000524858, T131416, T357032, uc.335+ was down regulated in the plasma of patients with preeclampsia. Pathway analysis showed the targeted mRNAs were enriched in apoptosis, sulfur metabolism, starch and sucrose metabolism. ceRNA network found that LncRNA-uc002ywy.3 might be the upstream regulator of miRNA-4498. LncRNA-uc002ywy.3/miRNA-4498 was predicted to interplay with genes involved in programmed cell death-1and its ligand (PD-1/PD-L1) pathway by KEGG analysis. Conclusion s PD-1/PD-L1 signaling pathway may be involved in the development of preeclampsia. The dysregulated LncRNA-uc002ywy.3/miRNA-4498 shed light on a new layer involved in the regulatory network of preeclampsia.
ER  -